Manatt is pleased to be sponsoring the Life Sciences Strategies for Anti-Corruption & FCPA Compliance Conference taking place June 22–24, 2011 in Washington, D.C. This conference will be addressing the unique challenges and risk areas tied to FCPA and corruption faced by the pharmaceuticals, medical device and biotechnology companies.

Manatt partner Jacqueline Wolff will be speaking on June 23 discussing "Developing Internal Controls to Manage & Monitor Interactions with Health Care Practitioners & Regulators at all Levels of the Organization."

She will cover:

• Defining a public official in foreign countries
• Assessing what interactions are permissible
• Developing and monitoring controls for HCP interactions in sales and marketing
• Comprehending the risks in clinical trials and developing controls for compliance
• Dissecting the risk in post marketing activities
• Creating awareness of high risk HCP interaction